Progressive watchdog organizations responded to the U.S. Senate Finance Committee’s Friday
hearing for Dr. Mehmet Oz by again sounding the alarm about the heart surgeon and former television host nominated to lead a key federal healthcare agency.

Since President Donald Trumpannounced Oz as his nominee for administrator of the Centers for Medicare and Medicaid Services (CMS) last November, opponents have spotlighted the doctor’s promotion of unproven products, investments in companies with interests in the federal agency, and support for expanding Medicare Advantage during an unsuccessful U.S. Senate run in 2022.

“Dr. Oz’s career promoting dubious medical treatments and pseudoscience often for personal financial gain should immediately disqualify him from serving in any public health capacity, let alone in a top administration health post,” Accountable.US executive director Tony Carrk said in a Friday statement.

“Dr. Oz’s nomination is part of President Trump’s grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections.”

In December, Carrk’s group
found that based on disclosures from Oz’s 2022 run against U.S. Sen. John Fetterman (D-Pa.), the Republican doctor reported “up to $56 million in investments in three companies” with direct CMS interests—including Sharecare, which became the “exclusive in-home care supplemental benefit program” for 1.5 million Medicare Advantage enrollees.

A spokesperson said at the time that Oz has since divested from Sharecare. However, critics have still expressed concern about how the nominee’s confirmation could boost Republican efforts to expand Medicare Advantage—health insurance plans for seniors administered by private companies rather than the government.

“As a self-interested advocate of privatizing Medicare at a higher cost and more denials of care for seniors, Dr. Oz is surely eager to enact the Trump-Republican budget plan to gut Medicare and Medicaid and jeopardize health coverage for millions of Americans—all to pay for more tax breaks for billionaires and price gouging corporations,” said Carrk. “Dr. Oz’s nomination is part of President Trump’s grand plan to enrich his corporate donors and wealthy friends while the rest of us get higher costs, less coverage, and weakened protections—especially those with preexisting conditions.”

Robert Weissman, co-president of the consumer advocacy group Public Citizen, has been similarly critical of Oz, and remained so after senators questioned him on Friday,
saying in a statement that “Mehmet Oz showed he is profoundly unqualified to lead any part of our healthcare system, let alone an agency as important as CMS.”

“Between his massive conflicts of interest across the healthcare sector and his endorsement of further privatizing Medicare, Oz would be a threat to the health of tens of millions of Americans,” Weissman warned. “Privatized
Medicare Advantage plans deliver inferior care and cost taxpayers nearly $100 billion annually in excess costs.”

“It is time for President Trump to put down the remote, stop finding nominees on television, and instead nominate people with actual experience and a belief in the importance of protecting crucial health programs like Medicare and Medicaid,” he argued, taking aim at not only the president but also his billionaire adviser Elon Musk, head of the so-called Department of Government Efficiency and, Robert F. Kennedy Jr., the conspiracy theorist now running the Department of Health and Human Services.

Weissman declared that “Trump, Musk, and RFK Jr. fail to put the American people first as they seek to gut agencies and make dangerous cuts to health programs to fund tax cuts for billionaires. Oz indicated he would not oppose such cuts, bringing more destruction to lifesaving programs. Oz has no place in government and should be roundly rejected by every senator.”

During a Friday exchange with Sen. Ron Wyden (D-Ore.), the committee’s ranking member, Oz refused to decisively commit to opposing cuts to Medicaid. As the Alliance for Retired Americans highlighted, Oz kept that up when given opportunities to revise his answer by Sens. Ben Ray Luján (D-N.M.) and Michael Bennet (D-Colo.).

Other moments from the hearing that garnered attention included Oz’s exchange with Sen. Catherine Cortez Masto (D-Nev.) about Affordable Care Act tax credits and Sen. Maggie Hassan (D-N.H.) calling out the doctor for his unwillingness “to take accountability for” his “promotion of unproven snake oil remedies” to millions of TV viewers.